News and Trends 11 Mar 2017 You Can Watch Fleming’s Original Penicillin Culture in Oxford! The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the current challenges of antibiotic resistance featuring the first culture used to extract the antibiotic. The discovery of penicillin by Alexander Fleming in the early 20th century changed the world of medicine. Antibiotics have saved millions […] March 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 9 Mar 2017 There’s a New Target for Anti-Aging Therapies According to a study at Queen Mary University of London (QMUL) published in the journal Cell Reports, the protein integrin-ß3 is a new marker and regulator of cellular senescence. Past research has revealed that the rising number of senescent cells, which appear during normal ageing, contributes to many age-related diseases. In a new study by Ana O’Loghlen and collegues, integrin-ß3 has been identified as […] March 9, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 6 Mar 2017 The ‘Underdog of the UK?’ 8 Companies Proving the Welsh Biotech Scene How is biotech in Wales? We take a look at some companies based in the ‘Land of Song,’ their plans and their achievements. After taking a look at the vibrant biotech clusters in the UK like London and Cambridge and picking the top biotechs in Scotland, it’s time to direct our attention to the western part […] March 6, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 6 Mar 2017 How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains We talked to the CEO of Bicycle Therapeutics, Kevin Lee, about how his company’s technology could cure not just cancer but also a raft of other diseases. Bicycle Therapeutics made a splashy debut in 2014 with a €25M fundraising round, only to outdo it with a €1B deal with AstraZeneca last fall. What’s the fuss? […] March 6, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2017 An HIV Vaccine Eliminates the Virus in a Patient for 7 Months An HIV vaccine developed at the University of Oxford has kept 5 out of 15 patients completely free of HIV. One of the patients has already been clear for 7 months. AIDS affects over 36.7 million people. Antiretroviral therapy (ART) is the most common treatment, which kills those cells in which the virus is active. However, HIV can remain inactive and […] March 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 27 Feb 2017 UK Lays Down a Foundation for Physical Science Innovation The UK government announced a €117M (£100M) investment to join the forces in physical sciences, engineering and life sciences through the new Rosalind Franklin research institute (RFI). Rosalind Franklin, the British scientist whose use of X-rays to study biological structures played a crucial role in the discovery of the DNA ‘double helix’, has laid some of the cornerstones in biophysical […] February 27, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
More News! 27 Feb 2017 Fundraising in the UK will Support Rare Disease Diagnostics Worldwide Congenica has raised £8M in its Series B financing round to sustain the international rollout of its clinical genome analysis platform Sapientia. Congenica is a genomic diagnostics company in Cambridge’s biotech cluster. Its genome analysis platform, Sapientia, takes on the challenge of interpreting the avalanche of genomic data becoming available in healthcare. The £8M (€9.5M) raised will sustain the […] February 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Feb 2017 Art Made with Human DNA Explores the Future of Genetics in Birmingham Gene Craft: Art in the Biogenetic Age opened this week at Birmingham Open Media (BOM) in the UK. Aiming to explore the social, economic and emotional implications of the most recent breakthroughs in genetics, the exhibition features two living art pieces created with human DNA by bioartists Laurie Ramsell and Gina Czarnecki. After the Human Fertilisation and Embryology Authority (HFEA) […] February 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2017 Reach for the BioStars! Meet the Top 3 Biotech Startups from Oxford A new round of this young startup competition is underway! What is this Oxford-based competition, and who competes? We talked to previous participants. BioStars is a flagship startups booster run by a group of PhDs, MBA and post-docs, who dedicate their spare time to enabling bio-entrepreneurs to turn their scientific ideas into actual products. Brought […] February 23, 2017 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2017 UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research. Its first four drug discovery programmes will now be launched. Apollo Therapeutics was founded in early 2016 as a collaborative effort of the three global pharmaceutical companies, AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation, and the world-leading UK-universities, Imperial College London, UCL and the University of […] February 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2017 Roche doubles down in Fight against Antibiotic Resistance In 2014, Discuva partnered up with Roche to develop new antibiotics against multidrug-resistant bacteria. The two companies have announced an extension of their collaboration until February 2018. The Cambridge-based company Discuva wants to address the critical need for new antibiotic drugs to treat infections from multidrug-resistant bacteria. Posing a major public health threat, antibiotic resistances cause at least 25,000 deaths per year in […] February 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2017 A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multiple sclerosis. Multiple sclerosis (MS) is a hot topic these days. While a recent long-term study revealed the potential of hematopoietic stem cell transplantation for the treatment of MS, this treatment strategy is […] February 21, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email